Welcome to our dedicated page for QT IMAGING HOLDINGS SEC filings (Ticker: QTI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
QT Imaging Holdings, Inc. (QTI) files SEC reports as a Nasdaq-listed medical device company focused on body imaging systems that use low-frequency sound waves. Its filings are useful for following how the company describes the commercialization, regulation and financing of its Breast Acoustic CT imaging platform.
Quarterly reports on Form 10-Q provide financial statements, accounting notes and management disclosures. For QTI, these reports have included items tied to breast scanning system placements, revenue expectations used in earnout liability valuation, warrants, reverse stock split adjustments and share information. Annual reports on Form 10-K, when filed, provide broader business, risk and financial disclosures.
Current reports on Form 8-K are especially relevant for QTI because they document material events between periodic reports. Recent 8-K categories include earnings releases, shareholder communications, financing agreements, stockholder meeting results, executive compensation actions and equity award grants. These filings help show how QT Imaging communicates operational updates, governance actions and capital markets activity.
The company's proxy statements describe matters submitted to stockholders, including director elections, auditor ratification and equity incentive plan proposals. For a medical device issuer such as QTI, SEC filings help investors evaluate the link between product commercialization, regulatory disclosures, governance decisions and the capital structure supporting the company's imaging technology business.
QT IMAGING HOLDINGS, INC. [QTIH] reporting person Dr. Avi S. Katz, identified as Chairman and a director, reported an acquisition of 25,000 stock options on 08/11/2025 with an exercise price of $1.90 and an expiration date of 08/11/2035. The filing lists the options as held directly and acquired under Transaction Code "A".
Vesting is defined: one-third vests on August 15, 2026 and the remaining two-thirds vest in eight equal quarterly installments on subsequent November 15, February 15, May 15, and August 15, completing on August 15, 2028, subject to continued service. The form is signed by Dr. Katz on 08/13/2025.
James S. Greene, a director of QT Imaging Holdings (ticker QTI), was granted 25,000 stock options on 08/11/2025 with an exercise price of $1.90. The options give the right to purchase 25,000 shares of common stock and carry an expiration date of 08/11/2035. The grant vests over time: one-third on August 15, 2026 and the remaining two-thirds in eight equal quarterly installments on each subsequent November 15, February 15, May 15 and August 15, fully vesting on August 15, 2028, subject to continued service. After the reported transaction Mr. Greene directly beneficially owns 25,000 options.
QT Imaging Holdings, Inc. reporting person Dr. Raluca Dinu, who serves as Chief Executive Officer and a director, was granted 25,000 stock options on 08/11/2025. The options have an exercise price of $1.90 and a stated expiration date of 08/11/2035, and are reported as directly owned following the grant.
The grant vests over roughly three years: one-third vests on August 15, 2026, and the remaining two-thirds vest in eight equal quarterly installments on each November 15, February 15, May 15 and August 15, with full vesting on August 15, 2028, subject to continued service. The award ties management compensation to future equity performance and would create dilution if exercised.
Daniel H. Dickson, a director of QT Imaging Holdings, Inc. (QTI), was granted a stock option to purchase 25,000 shares at an exercise price of $1.90 per share on 08/11/2025. The option is a direct holding, shows an expiration date of 08/11/2035, and is subject to a time-based vesting schedule: one-third vests on August 15, 2026, with the remaining two-thirds vesting in eight equal quarterly installments each November 15, February 15, May 15 and August 15, so the grant will be fully vested on August 15, 2028, contingent on continued service.
On 21 July 2025, Nasdaq Stock Market LLC filed Form 25 to remove QT Imaging Holdings, Inc. (ticker QTI) common stock from listing and registration under Section 12(b) of the Securities Exchange Act of 1934. The exchange certifies compliance with 17 CFR 240.12d2-2(b) for exchange-initiated delisting and notes that the issuer has satisfied voluntary withdrawal requirements under Rule 12d2-2(c). The notice, signed by Hearings Advisor Aravind Menon, covers only the company’s Common Stock; no financial results, operating updates, or explanatory rationale are provided. Once the SEC processes the filing, QTI shares will cease trading on Nasdaq and the registration will be withdrawn pursuant to the cited rules.